{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:00:56Z","timestamp":1790614856736,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.jaad.2013.12.025","type":"journal-article","created":{"date-parts":[[2014,3,15]],"date-time":"2014-03-15T11:45:24Z","timestamp":1394883924000},"page":"1096-1102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["HIV infection predisposes skin to toxic epidermal necrolysis via depletion of skin-directed CD4+ T cells"],"prefix":"10.1016","volume":"70","author":[{"given":"Chao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisa","family":"Mosam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avumile","family":"Mankahla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ncoza","family":"Dlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Saavedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2013.12.025_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaad.2006.04.048","article-title":"Toxic epidermal necrolysis","volume":"56","author":"Pereira","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.12.025_bib2","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jaad.2011.09.029","article-title":"Toxic epidermal necrolysis: review of pathogenesis and management","volume":"66","author":"Downey","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.12.025_bib3","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/eci.11.66","article-title":"The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"7","author":"Mockenhaupt","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaad.2013.12.025_bib4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.det.2006.06.008","article-title":"Adverse cutaneous drug eruptions and HIV: a clinician's global perspective","volume":"24","author":"Todd","year":"2006","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2013.12.025_bib5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0190-9622(92)70082-Q","article-title":"Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus","volume":"26","author":"Saiag","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.12.025_bib6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/qjmed\/hcs078","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome in South Africa: a 3-year prospective study","volume":"105","author":"Kannenberg","year":"2012","journal-title":"QJM"},{"key":"10.1016\/j.jaad.2013.12.025_bib7","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archderm.1993.01680290135026","article-title":"Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in Germany","volume":"129","author":"Rzany","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.12.025_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs; the EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.12.025_bib9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0738-081X(99)00144-3","article-title":"Adverse cutaneous drug reactions in patients with human immunodeficiency virus-1 infection","volume":"18","author":"Heller","year":"2000","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2013.12.025_bib10","first-page":"64","article-title":"Stevens-Johnson syndrome during anti-tuberculosis chemotherapy in HIV-seropositive patients: report on six cases","volume":"68","author":"Wirima","year":"1991","journal-title":"East Afr Med J"},{"key":"10.1016\/j.jaad.2013.12.025_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00015550310002611","article-title":"Severe cutaneous reactions associated with the use of human immunodeficiency virus medications","volume":"83","author":"Rotunda","year":"2003","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2013.12.025_bib12","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/eji.200425773","article-title":"Prevention of toxic epidermal necrolysis by regulatory T cells","volume":"35","author":"Azukizawa","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaad.2013.12.025_bib13","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1084\/jem.20072594","article-title":"Foxp3+ regulatory T cells maintain immune homeostasis in the skin","volume":"205","author":"Dudda","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2013.12.025_bib14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.12.025_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nri2916","article-title":"Phenotypical and functional specialization of FOXP3+ regulatory T cells","volume":"11","author":"Campbell","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaad.2013.12.025_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1034\/j.1600-065X.2001.1820104.x","article-title":"Control of T-cell activation by CD4+ CD25+ suppressor T cells","volume":"182","author":"Shevach","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaad.2013.12.025_bib17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaad.2013.12.025_bib18","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.4049\/jimmunol.0804002","article-title":"Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome","volume":"182","author":"Takahashi","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2013.12.025_bib19","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-3083.2009.02308.x","article-title":"How do regulatory T cells work?","volume":"70","author":"Corthay","year":"2009","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaad.2013.12.025_bib20","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.4049\/jimmunol.176.7.4431","article-title":"The vast majority of CLA+ T cells are resident in normal skin","volume":"176","author":"Clark","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2013.12.025_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF00424268","article-title":"Predominance of \u201cmemory\u201d T cells (CD4+, CDw29+) over \u201cnaive\u201d T cells (CD4+, CD45R+) in both normal and diseased human skin","volume":"281","author":"Bos","year":"1989","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2013.12.025_bib22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2230.1997.tb01038.x","article-title":"Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease; the military medical consortium for the advancement of retroviral research (MMCARR)","volume":"22","author":"Smith","year":"1997","journal-title":"Clin Exp Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214009888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214009888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:29:59Z","timestamp":1759271399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962214009888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0190962214009888"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2013.12.025","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV infection predisposes skin to toxic epidermal necrolysis via depletion of skin-directed CD4+ T cells","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2013.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}